Return on Innovation, Part 7: Outsourced Pharma Services: Differentiating Via Data

Outsourced Pharma Services: Differentiating Via Data 

Harris-Williams Bio-Crop 0040 JulianFeneley 1

Managing Director

Profile

Harris-Williams Bio-Crop 0067 1421 PaulHepper

Harris-Williams Bio-Crop 0021 089 DanLinsalata

Harris-Williams Bio-Crop 0003 AndreyDvorkin

Director

Harris-Williams Bio-Crop 0017 112 BeccaHerter

Vice President

Outsourced Pharma Services: Differentiating Via Data

Pharmalex

Germany

5543 Pharmalex (Project I) NT

Mergers & Acquisitions

The CM Group

United States

5679 The CM Group

Harris Williams advised Jordi Labs on its sale to RQM+, a portfolio company of Linden Capital Partners. Jordi Labs is a leader in analytical chemistry testing, delivering a full suite of regulatory, investigative, and related services to the medical device, pharmaceutical, and other industries.

Jordi Labs

5663 Jordi Labs NT

Harris Williams advised Medical Knowledge Group, a portfolio company of Court Square, on its sale to Novo Holdings. Medical Knowledge Group is an analytics-driven drug commercialization platform serving the biopharmaceutical industry.

Medical Knowledge Group

5490_medical_knowledge_group_mkg.png

Harris Williams advised Cerberus on its acquisition of a Clinical Trial Site Management Platform.

Clinical Trial Site Management Platform

5569_artc_project_atlantic_cerberus.png

Harris Williams advised RQM+, a portfolio company of DFW Capital Partners and Chartwell Investments Entrepreneur & Founder Capital (Chief Capital), on its sale to Linden Capital Partners. RQM+ provides regulatory and quality consulting and engineering for medical devices, in vitro diagnostics and combination products.

RQM+

5282_rqm.png

Harris Williams advised Velocity Clinical Research (Velocity), a portfolio company of NaviMed Capital, on its sale to Global Healthcare Opportunities, or GHO Capital Partners LLP. Velocity is a leading integrated site organization for clinical trials.

Velocity Clinical Research

5203-velocity-clinical-research.png

Harris Williams advised Kantar Health, a division of Kantar and portfolio company of Bain Capital Private Equity, on its sale to Cerner Corporation (NASDAQ: CERN ) . Kantar Health is a leading global healthcare data, analytics and research provider.

Kantar Health

4992kantar-health.png

Harris Williams advised Knox Lane, a leading middle market investment firm focused on the consumer and services sectors, on its strategic investment in Fingerpaint, a leading provider of analytics-enabled marketing solutions to biopharmaceutical customers.

Fingerpaint

5253fingerprint-marketing-project-charlie.png

Site Map

Privacy

Terms Of Use

Cookie Policy

Disclosures

We are a global investment bank specializing in M&A and private capital advisory services. Clients worldwide rely on us to help unlock value in their business and turn ambitious goals into reality.

About Us

Our Capabilities

We have eight dedicated Industry Groups led by senior professionals who have deep knowledge and experience across sectors, service offerings, and geographies.

Our Industries

Access our latest insights on evolving industry dynamics and marketplace trends.

Our Insights

Our momentum as a firm is strong. We carry this momentum forward by hiring people who are smart, driven, and principled. If you are a team player who thrives on collaborating with colleagues and clients, we invite you to learn more about our career opportunities. 

Return on Innovation, Part 7: Outsourced Pharma Services: Differentiating Via Data

Featured Engagements

Contacts

Return on Innovation: An Eight-Part Series

TICC in Healthcare and Life Sciences: TSS and Jordi Labs Highlight Investor Appeal

Medical Device Professional Services

Outsourced Pharma Services & Pharma Tech Q4 2022

Clinical Trial Technology: Emerging Trends & Opportunities

Return on Innovation, Part 7: Outsourced Pharma Services: Differentiating Via Data

Featured Engagements

Contacts

Related Insights

Return on Innovation: An Eight-Part Series

TICC in Healthcare and Life Sciences: TSS and Jordi Labs Highlight Investor Appeal

Medical Device Professional Services

Outsourced Pharma Services & Pharma Tech Q4 2022

Clinical Trial Technology: Emerging Trends & Opportunities